German OTC Market Woes Continue
Executive Summary
Germany's OTC market blues continue as the coronavirus lockdown bites into May.
You may also be interested in...
German OTC Market 2021: Firms Must Adapt To New E-Commerce And Product Portfolio Realities
In Germany, the coronavirus accelerated the shift towards online pharmacy and has strengthened certain OTC categories in 2020. Sales of hand sanitizers and vitamin and mineral supplements jumped while cough, cold and flu purchases weakened. Exploring the 2020 data, Sempora Consulting offers its advice for companies looking to adapt their strategies to the new reality.
Post-COVID Strategy: Invest, Don’t Save, Even If There's A Second Lockdown
What should consumer health companies be doing as Europe comes out of lockdown? Invest in key brands, says Sempora Consulting's managing partner Tobias Brodtkorb, and consider seizing the opportunity presented by the long-term trend for natural OTCs, which has been accelerated by the coronavirus pandemic.
German OTC Marketing Round-Up: Allergy Launches From Novartis, Hevert, Dermapharm And Bencard
OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard.